Literature DB >> 23613367

Clinical and molecular analysis in families with autosomal recessive osteogenesis imperfecta identifies mutations in five genes and suggests genotype-phenotype correlations.

José A Caparrós-Martin1, María Valencia, Veronica Pulido, Victor Martínez-Glez, Inmaculada Rueda-Arenas, Khalda Amr, Chantal Farra, Pablo Lapunzina, Victor L Ruiz-Perez, Samia Temtamy, Mona Aglan.   

Abstract

Autosomal recessive osteogenesis imperfecta (AR-OI) is an inherited condition which in recent years has been shown with increasing genetic and clinical heterogeneity. In this article, we performed clinical assessment and sought mutations in patients from 10 unrelated families with AR-OI, one of whom was presented with the additional features of Bruck syndrome (BS). Pathogenic changes were identified in five different genes: three families had mutations in FKBP10, three in SERPINF1, two in LEPRE1, one in CRTAP, and one in PPIB. With the exception of a FKBP10 mutation in the BS case, all changes are novel. Of note, insertion of an AluYb8 repetitive element was detected in exon 6 of SERPINF1. Since the studied patients had variable manifestations and some distinctive features, genotype/phenotype correlations are suggested.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23613367     DOI: 10.1002/ajmg.a.35938

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

1.  Novel Deletion of SERPINF1 Causes Autosomal Recessive Osteogenesis Imperfecta Type VI in Two Brazilian Families.

Authors:  Renata Moldenhauer Minillo; Nara Sobreira; Maria de Fatima de Faria Soares; Julie Jurgens; Hua Ling; Kurt N Hetrick; Kimberly F Doheny; David Valle; Decio Brunoni; Ana B Alvarez Perez
Journal:  Mol Syndromol       Date:  2014-11-25

2.  Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families.

Authors:  Osama Essawi; Sofie Symoens; Maha Fannana; Mohammad Darwish; Mohammad Farraj; Andy Willaert; Tamer Essawi; Bert Callewaert; Anne De Paepe; Fransiska Malfait; Paul J Coucke
Journal:  Mol Genet Genomic Med       Date:  2017-11-18       Impact factor: 2.183

3.  Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.

Authors:  G A Otaify; M S Aglan; M M Ibrahim; M Elnashar; R A S El Banna; S A Temtamy
Journal:  Osteoporos Int       Date:  2015-07-03       Impact factor: 4.507

4.  Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid.

Authors:  Xiao-Jie Xu; Fang Lv; Yi Liu; Jian-Yi Wang; Dou-Dou Ma; Jia-Wei Wang; Li-Jie Song; Yan Jiang; Ou Wang; Wei-Bo Xia; Xiao-Ping Xing; Mei Li
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

5.  Over-Representation of Recessive Osteogenesis Imperfecta in Asian Indian Children.

Authors:  Inusha Panigrahi; Yousaf Qureshi; Uwe Kornak
Journal:  J Pediatr Genet       Date:  2020-09-16

6.  Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade.

Authors:  Glenn S Belinsky; Bharath Sreekumar; Jillian W Andrejecsk; W Mark Saltzman; Jingjing Gong; Raimund I Herzog; Samantha Lin; Valerie Horsley; Thomas O Carpenter; Chuhan Chung
Journal:  FASEB J       Date:  2016-04-28       Impact factor: 5.191

7.  Homozygous sequence variants in the FKBP10 gene underlie osteogenesis imperfecta in consanguineous families.

Authors:  Muhammad Umair; Annum Hassan; Abid Jan; Farooq Ahmad; Muhammad Imran; Muhammad I Samman; Sulman Basit; Wasim Ahmad
Journal:  J Hum Genet       Date:  2015-11-05       Impact factor: 3.172

8.  Novel mutations in FKBP10 and PLOD2 cause rare Bruck syndrome in Chinese patients.

Authors:  Peiran Zhou; Yi Liu; Fang Lv; Min Nie; Yan Jiang; Ou Wang; Weibo Xia; Xiaoping Xing; Mei Li
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

9.  Mutations and altered expression of SERPINF1 in patients with familial otosclerosis.

Authors:  Joanna L Ziff; Michael Crompton; Harry R F Powell; Jeremy A Lavy; Christopher P Aldren; Karen P Steel; Shakeel R Saeed; Sally J Dawson
Journal:  Hum Mol Genet       Date:  2016-04-07       Impact factor: 6.150

10.  Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.

Authors:  Carla M Kaneto; Patrícia S P Lima; Dalila Lucíola Zanette; Thiago Yukio Kikuchi Oliveira; Francisco de Assis Pereira; Julio Cesar Cetrulo Lorenzi; Jane Lima Dos Santos; Karen L Prata; João M Pina Neto; Francisco J A de Paula; Wilson A Silva
Journal:  BMC Med Genet       Date:  2016-05-04       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.